According to LabCorp's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.36052. At the end of 2023 the company had a P/S ratio of 1.32.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.32 | -6.21% |
2022 | 1.40 | -24.81% |
2021 | 1.87 | 31.51% |
2020 | 1.42 | -0.34% |
2019 | 1.42 | 29.06% |
2018 | 1.10 | -29.1% |
2017 | 1.56 | 13.4% |
2016 | 1.37 | -4.95% |
2015 | 1.44 | -4.97% |
2014 | 1.52 | 12.63% |
2013 | 1.35 | -5.59% |
2012 | 1.43 | -7.1% |
2011 | 1.54 | -14.56% |
2010 | 1.80 | 7.18% |
2009 | 1.68 | 8.72% |
2008 | 1.54 | -25.08% |
2007 | 2.06 | -17.58% |
2006 | 2.50 | 22.14% |
2005 | 2.05 | -6.93% |
2004 | 2.20 | 22.08% |
2003 | 1.80 | 31.6% |
2002 | 1.37 | -47.2% |
2001 | 2.59 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() IDEXX Laboratories IDXX | 12.0 | 782.93% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | 1.63 | 19.90% | ๐บ๐ธ USA |
![]() Translate Bio
TBIO.defunct | N/A | N/A | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | 4.10 | 201.22% | ๐บ๐ธ USA |
![]() Qiagen QGEN | 4.80 | 252.49% | ๐ณ๐ฑ Netherlands |
![]() Enzo Biochem ENZ | 2.02 | 48.15% | ๐บ๐ธ USA |